Fortis Capital Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-9,300
Closed -$1.67M – 138
2023
Q4
$1.67M Hold
9,300
– – 0.43% 51
2023
Q3
$1.48M Buy
+9,300
New +$1.52M 0.46% 35

Other funds holding RGEN

Fortis Capital Management's RGEN Position: Q1 2024 in Review

Fortis Capital Management sold out of Repligen (RGEN) in Q1 2024, closing a stake of 9,300 shares — an estimated $1.67M sold.

Fortis Capital Management first reported a position in RGEN in Q3 2023 and held it in 2 quarters. The position peaked at $1.67M in Q4 2023. 487 funds tracked by Wall St. Rank hold RGEN as of Q1 2024.

  • Fortis Capital Management reported no remaining Repligen position as of Q1 2024 after selling out during the quarter.
  • Fortis Capital Management sold 9,300 Repligen shares in Q1 2024, an estimated $1.67M.
  • Fortis Capital Management first reported a position in Repligen in Q3 2023 and held it in 2 quarters.
  • Fortis Capital Management's Repligen position peaked at $1.67M in Q4 2023.
  • 487 funds tracked by Wall St. Rank held Repligen as of Q1 2024.

Based on Fortis Capital Management's 13F filing for Q1 2024, filed 30 Apr 2024.